Correction to: British Journal of Cancer 10.1038/s41416-021-01569-6, published online 06 October 2021
The original version of this article unfortunately contained a mistake. There was a misalignment in Fig. 1. In addition, Table 1 is incorrect. The authors apologize for the oversight. The original article has been corrected.
Table 1.
Clinicopathological features and CAV1 expression in CAFs.
| Total (n = 158) | CAV1 expression in CAFs | p value | ||
|---|---|---|---|---|
| Negative (n = 80) | Positive (n = 78) | |||
| Age (yr) | 67.3 ± 10.3 | 65.8 ± 10.7 | 68.7 ± 9.7 | 0.080 |
| Sex | 0.434 | |||
| Male | 88 (55.7%) | 47 (58.7%) | 41 (52.6%) | |
| Female | 70 (44.3%) | 33 (41.3%) | 37 (47.4%) | |
| BMI | 22.8 ± 3.2 | 22.4 ± 3.3 | 23.2 ± 3.1 | 0.117 |
| CEA (ng/mL) | 3.0 (0.6–1692) | 2.9 (0.6–1692) | 3.1 (0.7–150.1) | 0.123 |
| CA19-9 (ng/mL) | 36.0 (0–74,079) | 22.8 (0.1–36,230) | 54.1 (0–74,079) | 0.001 |
| PLT | 19.8 (5.1–296) | 19.6 (5.4–159) | 20.7 (5.1–296) | 0.953 |
| Total bilirubin (mg/dL) | 0.7 (0.1–13.4) | 0.7 (0.1–1.6) | 0.7 (0.2–13.4) | 0.548 |
| Albumin (g/dL) | 4.1 (2.6–5.1) | 4.1 (3.1–5.1) | 4.1 (2.6–4.9) | 0.615 |
| Tumor size (mm) | 39 (1–180) | 35 (1–120) | 40 (2.5–180) | 0.337 |
| pT | 0.046 | |||
| T0–2 | 109 (69.0%) | 61 (76.3%) | 48 (61.5%) | |
| T3, 4 | 49 (31.0%) | 19 (23.7%) | 30 (38.5%) | |
| pN | 0.004 | |||
| No | 128 (81.0%) | 72 (90.0%) | 56 (71.8%) | |
| Yes | 30 (19.0%) | 8 (10.0%) | 22 (28.2%) | |
| Operating time (min) | 369.9 ± 131.6 | 385.7 ± 137.6 | 353.7 ± 123.8 | 0.126 |
| Blood loss (mL) | 467.5 (2–5140) | 437.5 (5–2897) | 560 (29–5140) | 0.105 |
| Differentiation | 0.337 | |||
| Well/Mod | 107 (67.7%) | 57 (71.3%) | 50 (64.1%) | |
| Poor | 51 (32.3%) | 23 (28.7%) | 28 (35.9%) | |
| Postoperative chemotherapy | 0.523 | |||
| No | 117 (74.1%) | 61 (76.3%) | 56 (71.8%) | |
| Yes | 41 (25.9%) | 19 (23.7%) | 22 (28.2%) | |
CAV1 caveolin-1, CAFs cancer-associated fibroblasts, BMI body mass index, CEA carcinoembryonic antigen, CA19-9 carbohydrate antigen 19-9, pT pathological tumor stage, pN pathological nodal stage, Mod moderately, Poor poorly.